Ghrelin in Healthy and Frail Older Women

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Frailty
Interventions
DRUG

Ghrelin Infusion - Healthy

At time 0, a graded infusion of Ghrelin of 2.5, 5.0, and 10.0 pmol/kg/min infused in one of the IV sites for 60 minutes each, totalling 180 minutes when the infusion will be stopped.

DRUG

Ghrelin Infusion - Frail

At time 0, a graded infusion of Ghrelin of 2.5, 5.0, and 10.0 pmol/kg/min will be infused in one of the IV sites for 60 minutes each, totalling 180 minutes when the infusion will be stopped.

OTHER

Placebo Infusion -Healthy

At time 0, an infusion of saline will be started in one of the IV sites (an equivalent amount to compare to the Ghrelin infusion) and will be infused in a stepwise fashion continued until 180 minutes, when the infusion will be stopped.

OTHER

Placebo Infusion - Frail

At time 0, an infusion of saline will be started in one of the IV sites (an equivalent amount to compare to the Ghrelin infusion) and will be infused in a stepwise fashion continued until 180 minutes, when the infusion will be stopped.

Trial Locations (1)

19104

University of Pennsylvania Clinical and Translational Research Center, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT00520884 - Ghrelin in Healthy and Frail Older Women | Biotech Hunter | Biotech Hunter